This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Formed in 2007 by the merger of the Chicago Mercantile Exchange (CME) and the Chicago Board of Trade (CBOT), CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. The Chicago Mercantile Exchange was originally formed as a non-profit organization in 1898, but was converted to a for-profit company in 2000. It became the first publicly traded financial exchange in the U.S. in Dec 2002. CBOT, established in 1848, is a leading futures and options exchange. In Apr 2005, CBOT converted into a for-profit stock-based holding company and for-profit membership exchange subsidiary.
Cboe Global Q2 Earnings Surpass Estimates on Higher Revenues
by Zacks Equity Research
CBOE's Q2 results reflect growth in access and capacity fees, an increase in options average daily volume and higher non-transaction revenues.
Intercontinental Exchange Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
ICE posts record Q2 revenues and operating income, with strong gains across all segments and a 19% EPS jump.
NDAQ Beats Q2 Earnings & Revenue Estimates, Tweaks Expense View
by Zacks Equity Research
NDAQ beats Q2 estimates with 24% EPS growth and 13% revenue rise. It also revises the full-year expense outlook slightly.
Top Cryptocurrency Stocks to Buy Amid Regulatory Tailwinds
by Aniruddha Ganguly
Here, we pick three stocks, IREN, CIFR and HOOD, which are well-poised to benefit from the growing proliferation of Bitcoin and other cryptocurrencies.
CME Q2 Earnings, Revenues Beat Estimates on Higher Trading Volume
by Zacks Equity Research
CME posts Q2 beats on earnings and revenue as record trading volume and rising fees lift results amid market volatility.
Here's What Key Metrics Tell Us About CME (CME) Q2 Earnings
by Zacks Equity Research
The headline numbers for CME (CME) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CME Group (CME) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of +1.72% and +0.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Is a Beat in the Cards for CME Group This Earnings Season?
by Zacks Equity Research
CME's second-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and a strong market position.
Stay Ahead of the Game With CME (CME) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for CME (CME), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Nasdaq (NDAQ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME Group (CME) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will CME (CME) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
NDAQ Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
Nasdaq is set to grow on its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by a solid capital position.
3 Crypto-Focused Stocks to Buy as Bitcoin Heads Toward New High
by Ritujay Ghosh
With Bitcoin holding near $109K and optimism rising, V, CME, and BLK emerge as top crypto-exposed stocks to watch now.
MarketAxess Hits $1T in Credit Trades in 2Q25, But FPM Slips
by Kaibalya Pravo Dey
MKTX tops $1T in Q2 credit trades with strong fixed-income volumes, but fees per million take a hit from mix shifts.
Could CME Group's FX Tape+ be the Key to a More Transparent FX Market?
by Zacks Equity Research
CME is launching FX Tape+ to unify fragmented FX data into a real-time, centralized reference for global market transparency.
4 Crypto-Centric Stocks to Watch Closely Before the Next Bitcoin Rally
by Ritujay Ghosh
As Bitcoin holds firm near $107K, CME, ACN, V, and PYPL emerge as crypto-centric stocks with growth potential in 2025.
HOOD Unveils Micro Futures for BTC, SOL, XRP: Riding on Crypto Demand?
by Swayta Shah
Robinhood rolls out micro futures for BTC, SOL and XRP, aiming to widen crypto access and boost trading volume.
ICE Hits 52-Week High, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
Intercontinental rides on data services growth, mortgage network strength, and strategic buyouts, though rising expenses may weigh on near-term margins.
The Zacks Analyst Blog Highlights CME, Accenture, Visa and PayPal
by Zacks Equity Research
As Bitcoin rebounds, CME, ACN, V and PYPL gain traction with crypto offerings and rising earnings projections.
4 Crypto-Centric Stocks to Watch as Bitcoin Rebounds to Resume Rally
by Ritujay Ghosh
As Bitcoin rebounds past $105K after a ceasefire, CME, ACN, V and PYPL emerge as crypto-centric stocks with upside potential.
3 Bitcoin-Centric Stocks in Focus Amid Ongoing Geopolitical Tensions
by Ritujay Ghosh
As Bitcoin holds above $100K despite global tensions, CME, Visa and PayPal emerge as crypto plays with 2025 upside.
The Zacks Analyst Blog Highlights PayPal, Visa and CME
by Zacks Equity Research
Bitcoin tops $110K again, fueling gains for crypto-linked names like PYPL, V, and CME???all with rising earnings outlooks.
Bitcoin on Track to Hit New All-Time High: 3 Stocks in Focus
by Ritujay Ghosh
Crypto momentum returns as Bitcoin tops $110K, boosting outlooks for PYPL, V, and CME heading into 2025.